NDC Crossover 61755-021 Praluent

View and Compare Similar Products, Alternatives & Options

NDC Crossover of Similar Products Matching Alirocumab

Explore similar products and medications to NDC 61755-021 Praluent a human prescription drug with other products crossover matching the same product name (Praluent) or generic name (Alirocumab), and the same administration route (subcutaneous) or dosage form (injection, solution). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Product Type
0024-5901	Praluent	Alirocumab	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	Human Prescription Drug
0024-5902	Praluent	Alirocumab	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	Human Prescription Drug
0024-5903	Praluent	Alirocumab	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	Human Prescription Drug
0024-5904	Praluent	Alirocumab	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	Human Prescription Drug
61755-020	Praluent	Alirocumab	Injection, Solution	Subcutaneous	Regeneron Pharmaceuticals, Inc.	Human Prescription Drug
72733-5901	Praluent	Alirocumab	Injection, Solution	Subcutaneous	Sanofi Us Corporation	Human Prescription Drug
72733-5902	Praluent	Alirocumab	Injection, Solution	Subcutaneous	Sanofi Us Corporation	Human Prescription Drug